Approval · Notice of Compliance 31540 · 2023
BRIMONIDINE: Notice of Compliance 31540
Issued September 1, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31540
- Date
- September 1, 2023
- Company
- Micro Labs LimitedBangalore, Karnataka, India
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- ALPHAGAN (AbbVie Corporation)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BRIMONIDINE | 02540673 | Approved |
Medicinal ingredients
- BRIMONIDINE TARTRATE 2 MG per ML